Cui Shuna, Chen Tingting, Wang Mengmeng, Chen Yuanyuan, Zheng Qi, Feng Xinyi, Li Shihua, Wang Junsong
Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Medical College of Yangzhou University, Jiangyang Middle Road 136, Yangzhou 225001, China; Department of Gynecology And Obstetrics, Affiliated Hospital of Yangzhou University, Yangzhou, 225000, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou, 225000, China.
Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Medical College of Yangzhou University, Jiangyang Middle Road 136, Yangzhou 225001, China.
Phytomedicine. 2022 Apr;98:153958. doi: 10.1016/j.phymed.2022.153958. Epub 2022 Jan 29.
Cervical cancer is the most common malignancy of the female lower genital tract. Tanshinone I (Tan I) is one of the crucial lipid-soluble components of red sage (Salvia miltiorrhiza). While its mode of action against cervical cancer is unclear.
Our study aimed to explore the role of Tan I on cervical cancer in vitro.
Effects of Tan I on cervical cancer cells viability, migration and mitochondrial function were investigated by Cell Counting Kit-8, Transwell and Fluorescence laser confocal microscope assays respectively. The potential mechanism of Tan I was uncovered by an integrative approach combining RNA profiling and hydrogen nuclear magnetic resonance-based metabolic analysis, molecular docking and Western blot.
Tan I significantly inhibited the growth and colony formation of HeLa and SiHa cells. It induced apoptosis and cell cycle S phase arrest at low (12.5-25 μM) but not high (50 μM) concentrations. It also altered the HeLa cell ultrastructure, decreased the membrane potential and increased the total mitochondrial content. Further, Tan I induced autophagic flux and the colocalization of mitochondria with lysosomes, led to decreased adhesion, invasion, and migration of cervical cancer cells. Transcriptomic analysis revealed that Tan I altered the RNA profile and signal processing in HeLa cells. Tan I significantly impacted "central carbon metabolism in cancer" and "mitophagy-animal" processes. A global metabolic analysis identified 25 metabolites affected by Tan I treatment in HeLa cells. Changes in the metabolic profile indicated that Tan I affected such processes as protein digestion and absorption, central carbon metabolism in cancer, and aminoacyl-tRNA biosynthesis in cervical cancer cells. Furthermore, Tan I significantly induced the expression of mitophagy-related proteins BNIP3, NIX and Optineurin and the conversion from LC3-I to LC3-II, inhibited the NDP52 and P62 level in a concentration-dependent manner. While CQ further increased the conversion of LC3-I to LC3-II and the expression of P62. Moreover, Tan I interacted with BNIP3 and NIX through hydrogen bond. Tan I induce mitophagy could be prevented by BNIP3 and NIX siRNA transfection.
Tan I induced the BNIP3/NIX-mediated mitophagy, and reprogrammed the mitochondrial metabolism in cervical cancer cells, thus inhibiting metastasis.
宫颈癌是女性下生殖道最常见的恶性肿瘤。丹参酮I(Tan I)是丹参(Salvia miltiorrhiza)的关键脂溶性成分之一。但其对宫颈癌的作用机制尚不清楚。
本研究旨在探讨Tan I在体外对宫颈癌的作用。
分别采用细胞计数试剂盒-8、Transwell和荧光激光共聚焦显微镜检测Tan I对宫颈癌细胞活力、迁移和线粒体功能的影响。通过RNA谱分析、基于氢核磁共振的代谢分析、分子对接和蛋白质印迹相结合的综合方法揭示Tan I的潜在机制。
Tan I显著抑制HeLa和SiHa细胞的生长和集落形成。在低浓度(12.5 - 25 μM)而非高浓度(50 μM)时诱导细胞凋亡和细胞周期S期阻滞。它还改变了HeLa细胞的超微结构,降低了膜电位并增加了线粒体总量。此外,Tan I诱导自噬流以及线粒体与溶酶体的共定位,导致宫颈癌细胞的黏附、侵袭和迁移减少。转录组分析显示Tan I改变了HeLa细胞中的RNA谱和信号处理。Tan I显著影响“癌症中的中心碳代谢”和“线粒体自噬 - 动物”过程。全局代谢分析确定了25种受Tan I处理影响的HeLa细胞代谢物。代谢谱的变化表明Tan I影响宫颈癌细胞中的蛋白质消化和吸收、癌症中的中心碳代谢以及氨酰 - tRNA生物合成等过程。此外,Tan I显著诱导线粒体自噬相关蛋白BNIP3、NIX和视黄醛结合蛋白(Optineurin)的表达以及LC3 - I向LC3 - II的转化,以浓度依赖的方式抑制NDP52和P62水平。而氯喹(CQ)进一步增加了LC3 - I向LC3 - II的转化和P62的表达。此外,Tan I通过氢键与BNIP3和NIX相互作用。Tan I诱导的线粒体自噬可通过BNIP3和NIX siRNA转染来预防。
Tan I诱导BNIP3 / NIX介导的线粒体自噬,并重新编程宫颈癌细胞中的线粒体代谢,从而抑制转移。